A Study of Imlunestrant (LY3484356) in Female Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of LY3541105 in Healthy and Overweight Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
- Status
- COMPLETED
- Phase
- PHASE3
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
- Status
- RECRUITING
- Phase
- PHASE4
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Single and Repeated Doses of LY3556050 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Two Different Formulations of LY3502970 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Selpercatinib (LY3527723) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1